Rise of the (possible) resistance: a review of susceptibility patterns for nontyphoidal Salmonella enterica in Nebraska.

Autor: Sunagawa SW; Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, NE, USA.; College of Pharmacy, University of Nebraska Medicine Center, Omaha, NE, USA., Christopherson C; College of Pharmacy, University of Nebraska Medicine Center, Omaha, NE, USA., Bergman SJ; Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, NE, USA.; College of Pharmacy, University of Nebraska Medicine Center, Omaha, NE, USA., Miller MM; Department of Pharmaceutical and Nutrition Care, Nebraska Medicine, Omaha, NE, USA., Keintz MR; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA., Wahlig TA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Fey P; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Van Schooneveld TC; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Jazyk: angličtina
Zdroj: Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2023 Oct 23; Vol. 3 (1), pp. e181. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
DOI: 10.1017/ash.2023.464
Abstrakt: Our institution sought to evaluate our antimicrobial stewardship empiric treatment recommendations for Salmonella . Results from 36 isolates demonstrated reduced susceptibilities to fluoroquinolones with 1 isolate susceptible only to ceftriaxone. Analysis supports the current recommendation of empiric ceftriaxone therapy for severe infection and updated recommendation for sulfamethoxazole-trimethoprim in non-severe infections.
Competing Interests: All authors report no conflicts of interest relevant to this article.
(© The Author(s) 2023.)
Databáze: MEDLINE